Tempus AI (NASDAQ:TEM) Stock Price Up 3.1% – Still a Buy?

Tempus AI, Inc. (NASDAQ:TEM) rose 3.1% on Tuesday . The stock traded as high as $68.81 and last traded at $67.70. Approximately 3,230,482 shares traded hands during mid-day trading, a decline of 54% from the average daily volume of 7,093,864 shares. The stock had previously closed at $65.65.

Analyst Upgrades and Downgrades

TEM has been the topic of several research analyst reports. Guggenheim reissued a “buy” rating on shares of Tempus AI in a research note on Tuesday, February 25th. JPMorgan Chase & Co. downgraded shares of Tempus AI from an “overweight” rating to a “neutral” rating and boosted their price objective for the company from $50.00 to $55.00 in a research report on Tuesday, February 25th. Wolfe Research cut shares of Tempus AI from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, February 26th. BTIG Research began coverage on shares of Tempus AI in a research report on Monday, April 21st. They set a “buy” rating and a $60.00 price target on the stock. Finally, Needham & Company LLC reissued a “buy” rating and issued a $70.00 price target on shares of Tempus AI in a research note on Wednesday, May 7th. Six analysts have rated the stock with a hold rating and seven have given a buy rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $63.42.

Tempus AI Stock Up 0.3%

The company has a quick ratio of 1.56, a current ratio of 1.71 and a debt-to-equity ratio of 2.45. The company’s fifty day moving average price is $59.18 and its 200-day moving average price is $52.81. The stock has a market capitalization of $11.40 billion and a PE ratio of -8.45.

Tempus AI (NASDAQ:TEM) last released its earnings results on Tuesday, May 6th. The company reported ($0.24) EPS for the quarter, topping the consensus estimate of ($0.27) by $0.03. The business had revenue of $255.74 million for the quarter, compared to the consensus estimate of $248.13 million. Tempus AI had a negative return on equity of 533.21% and a negative net margin of 88.27%. Tempus AI’s revenue for the quarter was up 75.4% compared to the same quarter last year. Analysts forecast that Tempus AI, Inc. will post -6.15 earnings per share for the current year.

Insiders Place Their Bets

In other Tempus AI news, Director Wayne A.I. Frederick sold 3,000 shares of Tempus AI stock in a transaction on Monday, March 31st. The stock was sold at an average price of $45.54, for a total value of $136,620.00. Following the completion of the sale, the director now owns 26,514 shares of the company’s stock, valued at approximately $1,207,447.56. This trade represents a 10.16% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, COO Ryan Fukushima sold 20,000 shares of Tempus AI stock in a transaction dated Tuesday, May 6th. The stock was sold at an average price of $52.36, for a total value of $1,047,200.00. Following the completion of the sale, the chief operating officer now owns 884,460 shares of the company’s stock, valued at $46,310,325.60. The trade was a 2.21% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 609,897 shares of company stock valued at $41,397,783. Insiders own 27.60% of the company’s stock.

Institutional Investors Weigh In On Tempus AI

Several institutional investors and hedge funds have recently added to or reduced their stakes in the stock. First Horizon Advisors Inc. boosted its stake in shares of Tempus AI by 12.7% in the 1st quarter. First Horizon Advisors Inc. now owns 1,849 shares of the company’s stock worth $89,000 after buying an additional 208 shares during the last quarter. Wells Fargo & Company MN lifted its holdings in Tempus AI by 13.2% in the fourth quarter. Wells Fargo & Company MN now owns 2,384 shares of the company’s stock valued at $80,000 after acquiring an additional 278 shares during the period. Bartlett & CO. Wealth Management LLC boosted its position in Tempus AI by 100.0% in the first quarter. Bartlett & CO. Wealth Management LLC now owns 800 shares of the company’s stock worth $39,000 after purchasing an additional 400 shares during the last quarter. Mirae Asset Global Investments Co. Ltd. grew its stake in shares of Tempus AI by 10.1% during the 1st quarter. Mirae Asset Global Investments Co. Ltd. now owns 5,594 shares of the company’s stock valued at $268,000 after purchasing an additional 515 shares during the period. Finally, Cherry Tree Wealth Management LLC bought a new stake in shares of Tempus AI during the 1st quarter valued at about $31,000. Hedge funds and other institutional investors own 24.22% of the company’s stock.

Tempus AI Company Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.